Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kazama

Showing results (11-20 of 146) with videos related to

Pageof 15
Sort By:
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|December 1, 1988
Clinical evaluation of hemostatic molecular markersM Kazama
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 10, 1991
[Progress on thrombolytic treatment]M Kazama
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 1, 1995
[FDP-E fraction]M Kazama
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 10, 1974
[Coagulation, fibrinolysis and various diseases: nephritis]M Kazama
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 1, 1981
[Detection of hemophilia carrier and prenatal diagnosis]M Kazama
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|December 1, 1978
Characterization of soluble fibrinogen/fibrin monomer complex (SFMC) for the analysis of primary and secondary fibrinolysis in DICM Kazama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 1, 1977
[Clinical evaluation of thrombolytic therapy, with special reference to SFMC in the circulating blood (author's transl)]M Kazama
Kurinikaru Sutadi = Clinical Study|January 1, 1989
[Errors in your nursing: nursing of a patient who refuses nursing assistance; nursing of a highly apprehensive patient with complaints of pain]R Hirayama, M Kazama
Thrombosis Research|May 1, 1976
Change of the molecular mass of fibrinogen in circulating blood, as an index of the hypercoagulable statesM Kazama, T Abe
Thrombosis Research|May 1, 1976
Defibrination syndrome as drastic deviation of coagulation and fibrinolysis balance and its therapeutic managementT Abe, M Kazama
Pageof 15

Showing results (11-20 of 146) with videos related to

Sort By:
Pageof 15
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|December 1, 1988
Clinical evaluation of hemostatic molecular markersM Kazama
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 10, 1991
[Progress on thrombolytic treatment]M Kazama
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 1, 1995
[FDP-E fraction]M Kazama
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 10, 1974
[Coagulation, fibrinolysis and various diseases: nephritis]M Kazama
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 1, 1981
[Detection of hemophilia carrier and prenatal diagnosis]M Kazama
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|December 1, 1978
Characterization of soluble fibrinogen/fibrin monomer complex (SFMC) for the analysis of primary and secondary fibrinolysis in DICM Kazama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 1, 1977
[Clinical evaluation of thrombolytic therapy, with special reference to SFMC in the circulating blood (author's transl)]M Kazama
Kurinikaru Sutadi = Clinical Study|January 1, 1989
[Errors in your nursing: nursing of a patient who refuses nursing assistance; nursing of a highly apprehensive patient with complaints of pain]R Hirayama, M Kazama
Thrombosis Research|May 1, 1976
Change of the molecular mass of fibrinogen in circulating blood, as an index of the hypercoagulable statesM Kazama, T Abe
Thrombosis Research|May 1, 1976
Defibrination syndrome as drastic deviation of coagulation and fibrinolysis balance and its therapeutic managementT Abe, M Kazama
Pageof 15